(Total Views: 281)
Posted On: 04/19/2018 4:04:50 PM
Post# of 72447
3 different drugs, multiple successful clinical trials for at least 5 different applications of the drugs.
Market cap: 63 million.
Anyone who thinks that this stock is fairly priced is not paying attention.
NNVC market cap: 50 million. No clinical trials and no prospects for any.
AVXL market cap 101 million. One very small clinical trial for an Alzheimer's drug. Alz drugs notoriously don't work.
AXON market cap 121 million. Gigantic failure in clinical trial.
Market cap: 63 million.
Anyone who thinks that this stock is fairly priced is not paying attention.
NNVC market cap: 50 million. No clinical trials and no prospects for any.
AVXL market cap 101 million. One very small clinical trial for an Alzheimer's drug. Alz drugs notoriously don't work.
AXON market cap 121 million. Gigantic failure in clinical trial.
(2)
(0)
